ZLDAF (Zelira Therapeutics) Dividends per Share: $0.00 (TTM As of Jun. 2025)

What is Zelira Therapeutics Dividends per Share?

Zelira Therapeutics ZLDAF 9 Dividends per Share is $0.00 as of Jun. 2025. GuruFocus rates ZLDAF with a GF Score™ of 9/100 and a GF Value™ of $0.06 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Zelira Therapeutics's dividends per share for the six months ended in Jun. 2025 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2025 was $0.00. Its Dividend Payout Ratio for the six months ended in Jun. 2025 was 0.00. As of today, Zelira Therapeutics's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Zelira Therapeutics (OTCPK:ZLDAF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Zelira Therapeutics's Dividend Payout Ratio for the quarter that ended in Jun. 2025 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2025 )	/	EPS without NRI (Q: Jun. 2025 )
	=	0	/	-0.063
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zelira Therapeutics Dividends per Share Related Terms

Zelira Therapeutics Dividends per Share Historical Data

* Premium members only.

The historical data trend for Zelira Therapeutics's Dividends per Share can be seen below:

Zelira Therapeutics Dividends per Share Chart

Zelira Therapeutics Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Dividends per Share

Get a 7-Day Free Trial

0.00

Zelira Therapeutics Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25
Dividends per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

ZLDAF vs MTNB, SXTP, GLMD: Dividends per Share Comparison

For the Biotechnology subindustry, Zelira Therapeutics's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zelira Therapeutics Dividend Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zelira Therapeutics's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Zelira Therapeutics's Dividend Yield % falls into.

Save Embed

9GF Score

Zelira Therapeutics Ltd ZLDAF

Dividends per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Zelira Therapeutics Dividends per Share Calculation

Dividends paid to per common share.

Frequently Asked Questions Learn more about Dividends per Share →

What does a Dividends per Share of $0.00 mean?

Zelira Therapeutics (ZLDAF) has a Dividends per Share of $0.00 as of Jun. 2025. Dividends per share represents the per-share amount paid as dividends. View historical data on Zelira Therapeutics and its competitors.

Is Zelira Therapeutics' Dividends per Share too high?

Zelira Therapeutics' current Dividends per Share is $0.00. Overall, Zelira Therapeutics has a GF Score™ of 9/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Zelira Therapeutics' Dividends per Share compare to MTNB and SXTP?

Zelira Therapeutics' Dividends per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Dividends per Share for a Biotechnology company?

A good Dividends per Share depends on the Biotechnology industry context. However, Dividends per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Dividends per Share mean?

A high Dividends per Share can signal that a stock is expensive relative to its fundamentals. Dividends per share represents the per-share amount paid as dividends. View historical data on Zelira Therapeutics and its competitors. Zelira Therapeutics's current Dividends per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Zelira Therapeutics stock overvalued right now?

Based on GuruFocus' analysis, Zelira Therapeutics (ZLDAF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.06, compared to a current price of $0.30 — trading 400% above its estimated fair value. The current Dividends per Share is $0.00. Zelira Therapeutics' overall GF Score™ is 9/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Dividends per Share calculated?

Dividends per Share is calculated from a company's financial statements. For Zelira Therapeutics (ZLDAF), the current Dividends per Share is $0.00 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zelira Therapeutics (ZLDAF) Overvalued in 2026?

Based on GuruFocus' analysis, Zelira Therapeutics stock appears to be overvalued. The current stock price of $0.30 is trading 400% above its estimated GF Value™ of $0.06. GuruFocus considers Zelira Therapeutics to be Significantly Overvalued.

Key valuation signals for ZLDAF:

Dividends per Share: $0.00
GF Value™: $0.06 vs. price of $0.30 (400% above fair value)
GF Score™: 9/100 with 7 warning signs

No single metric tells the full story. See the ZLDAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zelira Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies MTNB SXTP GLMD FBLG ARTL CELZ REVB ALZN RNAZ ENSC VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000

Website https://www.zeliratx.com

Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema, and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer. The company is organised into two operating segments based on geographic location of operations: Australia and United States of America.

9GF Score

Get the complete analysis for ZLDAF

Dividends per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30

Price

$0.06

GF Value

View ZLDAF Analysis

See Dividends per Share data for all stocks →